Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
XORTX Therapeutics Inc.
Market Cap
$481786.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$527596.00
Net Profit Margin
-11016.07%
TTM Avg
-6147.48%
3Y Avg
-7604.80%
5Y Avg
-5197.06%
Market Cap
$566203.00
Net Profit Margin
-73.22%
TTM Avg
-7923.42%
3Y Avg
-4237.01%
5Y Avg
-2848.17%
Market Cap
$401484.00
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-352.76%
5Y Avg
-376.69%
Market Cap
$356454.00
Net Profit Margin
-40439.10%
TTM Avg
-68089.13%
3Y Avg
-51057.85%
5Y Avg
-34126.19%
Market Cap
$701131.00
Net Profit Margin
6.30%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$715847.00
Net Profit Margin
N/A
TTM Avg
-384.13%
3Y Avg
-307.48%
5Y Avg
-251.31%
Market Cap
$246973.00
Net Profit Margin
-1422.78%
TTM Avg
-951.97%
3Y Avg
-568.57%
5Y Avg
-575.76%
Market Cap
$814420.00
Net Profit Margin
N/A
TTM Avg
3.77%
3Y Avg
-2.35%
5Y Avg
-2.90%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XORTX Therapeutics Inc. (XRTX) | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| VivoSim Labs, Inc. (VIVS)vs › | $527596.00 | -11016.07% | -6147.48% | -7604.80% | -5197.06% |
| HCW Biologics Inc. (HCWB)vs › | $566203.00 | -73.22% | -7923.42% | -4237.01% | -2848.17% |
| Niki BioSolutions, Inc. (NIKI)vs › | $401484.00 | 0.00% | 0.00% | -352.76% | -376.69% |
| Virax Biolabs Group Limited (VRAX)vs › | $356454.00 | -40439.10% | -68089.13% | -51057.85% | -34126.19% |
| CDT Equity Inc. (CDT)vs › | $701131.00 | 6.30% | 0.00% | 0.00% | 0.00% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $715847.00 | N/A | -384.13% | -307.48% | -251.31% |
| SciSparc Ltd. (SPRC)vs › | $246973.00 | -1422.78% | -951.97% | -568.57% | -575.76% |
| Ridgetech, Inc. (RDGT)vs › | $814420.00 | N/A | 3.77% | -2.35% | -2.90% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $827668.00 | 0.00% | 0.00% | -933.28% | -622.19% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
